CAS 196618-13-0: Oseltamivir
Formula:C16H28N2O4
InChI:InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1
InChI key:InChIKey=VSZGPKBBMSAYNT-RRFJBIMHSA-N
SMILES:O(C(CC)CC)[C@H]1[C@H](NC(C)=O)[C@@H](N)CC(C(OCC)=O)=C1
Synonyms:- 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-
- 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, [3R-(3α,4β,5α)]-
- Ebilfumin
- Enfluvir
- Ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
- GOP-A-Flu
- Gs 4104
- Oseltamivr
- Tamiflu-Free
- Tamvir
- Zinc 039295508
- See more synonyms
Sort by
Found 11 products.
Oseltamivir
CAS:Formula:C16H28N2O4Purity:>98.0%(T)(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:312.41Oseltamivir
CAS:Inhibitor of viral neuraminidase enzyme, effective against influenza A and B viruses. This antiviral compound inhibits neuraminidase-mediated cleavage of host cell sialic acids, which interact with newly synthesised virions from the host cell. This prevents virion budding from the host, resulting in inhibition of virion release and viral infection overall.Formula:C16H28N2O4Purity:Min. 95 Area-%Color and Shape:PowderMolecular weight:312.4 g/molOseltamivir
CAS:Oseltamivir (GS 4104) is an orally active and highly potent viral neuraminidase (NA) with antiviral activity, inhibits A/H3N2, A/H1N2, A/H1N1 and influenza B viruses, and can be used in studies of influenza and pneumonia.Formula:C16H28N2O4Purity:99.28%Color and Shape:SolidMolecular weight:312.4Oseltamivir 100 µg/mL in Acetonitrile
CAS:Formula:C16H28N2O4Color and Shape:Single SolutionMolecular weight:312.40(3R,4R,5S)-Ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
CAS:Formula:C16H28N2O4Purity:97%Color and Shape:SolidMolecular weight:312.4045Oseltamivir
CAS:Applications Oseltamivir is an orally active inhibitor of influenza virus neuraminidase; converted in vivo to the active acid metabolite. An antiviral drug. It is a COVID19-related research product. References Oliyai, R., et al.: Pharm. Res., 15, 1300 (1998), Kim, C.U., et al.: Med. Chem. Res., 8, 392 (1998), Hayden, F.G., et al.: N. Engl. J. Med., 341, 1336 (1999), Treanor, J.J., et al.: J. Am. Med. Assoc., 283, 1016 (2000)Formula:C16H28N2O4Color and Shape:Light YellowMolecular weight:312.40
